• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙酰半胱氨酸通过调节肠道微生态缓解高脂饮食诱导的小鼠肝脂肪变性和肝损伤。

-Acetylcysteine alleviates high fat diet-induced hepatic steatosis and liver injury regulating the intestinal microecology in mice.

机构信息

School of Public Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, PR. China.

College of Animal Science, Zhejiang University, Hangzhou, Zhejiang, PR. China.

出版信息

Food Funct. 2022 Mar 21;13(6):3368-3380. doi: 10.1039/d1fo03952k.

DOI:10.1039/d1fo03952k
PMID:35229847
Abstract

-Acetylcysteine (NAC), a well-accepted antioxidant, has been shown to protect against high fat diet (HFD)-induced obesity-associated non-alcoholic fatty liver disease (NAFLD) in mice. However, the underlying mechanism(s) of the beneficial role of NAC is still not fully understood. Our study aimed to evaluate the protective effect of NAC against NAFLD in terms of gut microbiota homeostasis. Thirty-two C57BL/6 mice were divided into four groups, including chow diet (CHOW), high-fat diet (HFD), CHOW + NAC (2 g L in the drinking water), and HFD + NAC groups, and fed for 12 weeks. NAC supplementation significantly improved HFD-induced obesity, dyslipidemia, and liver dysfunction in mice. NAC also rescued HFD-caused disorder of the gut microbiota. Intriguingly, removing intestinal microorganisms by antibiotics (ABX) obviously abolished NAC supplementation-rescued hepatic steatosis and liver injury, indicating the involvement of the gut microbiota in the beneficial role of NAC. The profiles of 1145 expressed hepatic mRNAs were analyzed by whole transcriptome sequencing. Among those, 5 up-expressed mRNAs induced by a HFD, including , , , , and , were reversed by NAC treatment, which was further verified by a quantitative real-time polymerase chain reaction (qRT-PCR). Meanwhile, those 5 mRNAs exhibited a significant (negative or positive) association with bacterial phyla or genera, including phyla and and genera and , by Spearman's correlation analysis. These results suggested that the homeostasis of the gut microbiota plays an important role in NAC-improved NAFLD by affecting the enterohepatic axis.

摘要

乙酰半胱氨酸(NAC)作为一种公认的抗氧化剂,已被证明可预防高脂肪饮食(HFD)诱导的肥胖相关非酒精性脂肪性肝病(NAFLD)。然而,NAC 有益作用的潜在机制仍不完全清楚。我们的研究旨在评估 NAC 在肠道微生物组平衡方面对 NAFLD 的保护作用。将 32 只 C57BL/6 小鼠分为 4 组,包括普通饮食(CHOW)、高脂肪饮食(HFD)、CHOW+NAC(2 g L 在饮水中)和 HFD+NAC 组,喂养 12 周。NAC 补充显著改善了 HFD 诱导的肥胖、血脂异常和肝功能障碍。NAC 还挽救了 HFD 引起的肠道微生物群紊乱。有趣的是,用抗生素(ABX)去除肠道微生物明显消除了 NAC 补充对肝脂肪变性和肝损伤的挽救作用,表明肠道微生物群参与了 NAC 的有益作用。通过全转录组测序分析了 1145 个表达的肝 mRNA 谱。其中,5 个由 HFD 诱导的上调 mRNA,包括、、、和,被 NAC 处理逆转,这通过定量实时聚合酶链反应(qRT-PCR)进一步验证。同时,通过 Spearman 相关分析,这些 5 个 mRNA 与细菌门或属呈显著(负相关或正相关)相关,包括门和和属和。这些结果表明,肠道微生物组的平衡通过影响肠肝轴在 NAC 改善 NAFLD 中起着重要作用。

相似文献

1
-Acetylcysteine alleviates high fat diet-induced hepatic steatosis and liver injury regulating the intestinal microecology in mice.乙酰半胱氨酸通过调节肠道微生态缓解高脂饮食诱导的小鼠肝脂肪变性和肝损伤。
Food Funct. 2022 Mar 21;13(6):3368-3380. doi: 10.1039/d1fo03952k.
2
N-Acetylcysteine alleviates gut dysbiosis and glucose metabolic disorder in high-fat diet-fed mice.N-乙酰半胱氨酸可缓解高脂饮食喂养小鼠的肠道菌群失调和糖代谢紊乱。
J Diabetes. 2019 Jan;11(1):32-45. doi: 10.1111/1753-0407.12795. Epub 2018 Jul 4.
3
Gut microbiota of miR-30a-5p-deleted mice aggravate high-fat diet-induced hepatic steatosis by regulating arachidonic acid metabolic pathway.miR-30a-5p 缺失小鼠的肠道微生物群通过调节花生四烯酸代谢途径加重高脂肪饮食诱导的肝脂肪变性。
Clin Transl Med. 2024 Oct;14(10):e70035. doi: 10.1002/ctm2.70035.
4
Hepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota.肝胆胰:多供体粪便微生物群移植通过重塑肠道微生物群来减轻高脂肪饮食诱导的小鼠肝脂肪变性。
J Gastroenterol Hepatol. 2023 Dec;38(12):2195-2205. doi: 10.1111/jgh.16359. Epub 2023 Oct 3.
5
Long term N-acetylcysteine administration rescues liver steatosis via endoplasmic reticulum stress with unfolded protein response in mice.长期给予 N-乙酰半胱氨酸通过内质网应激未折叠蛋白反应挽救小鼠肝脂肪变性。
Lipids Health Dis. 2020 May 25;19(1):105. doi: 10.1186/s12944-020-01274-y.
6
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.槲皮素对高脂饮食诱导的小鼠非酒精性脂肪性肝病的保护作用是通过调节肠道微生物群失衡和相关肠-肝轴激活来介导的。
Free Radic Biol Med. 2017 Jan;102:188-202. doi: 10.1016/j.freeradbiomed.2016.11.037. Epub 2016 Nov 25.
7
Housing condition-associated changes in gut microbiota further affect the host response to diet-induced nonalcoholic fatty liver.住房条件相关的肠道微生物组变化进一步影响宿主对饮食诱导的非酒精性脂肪肝的反应。
J Nutr Biochem. 2020 May;79:108362. doi: 10.1016/j.jnutbio.2020.108362. Epub 2020 Feb 24.
8
Deletion of the PPARδ gene exacerbates high-fat diet-induced nonalcoholic fatty liver disease in mice through the gut-liver axis.PPARδ基因的缺失通过肠-肝轴加剧了高脂饮食诱导的小鼠非酒精性脂肪性肝病。
Cell Mol Biol (Noisy-le-grand). 2023 Oct 31;69(10):121-128. doi: 10.14715/cmb/2023.69.10.17.
9
N-acetylcysteine Protects Mice from High Fat Diet-induced Metabolic Disorders.N-乙酰半胱氨酸可保护小鼠免受高脂饮食诱导的代谢紊乱。
Pharm Res. 2016 Aug;33(8):2033-42. doi: 10.1007/s11095-016-1941-1. Epub 2016 May 9.
10
Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.红肉火龙果花青素通过调节小鼠肠道微生物群,预防饮食诱导的肥胖、肝脏脂肪变性和胰岛素抵抗。
J Gastroenterol Hepatol. 2016 Aug;31(8):1462-9. doi: 10.1111/jgh.13278.

引用本文的文献

1
D-glucaro-1,4-lactone alleviates acetaminophen-induced hepatotoxicity in mice via modulating gut microbiota and metabolites associated with -glutamine and nicotinic acid pathways.D-葡萄糖酸-1,4-内酯通过调节与谷氨酰胺和烟酸途径相关的肠道微生物群和代谢产物来减轻对乙酰氨基酚诱导的小鼠肝毒性。
Front Pharmacol. 2025 Jul 9;16:1627850. doi: 10.3389/fphar.2025.1627850. eCollection 2025.
2
Immune Microenvironment on the Molecular Mechanisms and Therapeutic Targets of MAFLD.免疫微环境对MAFLD分子机制及治疗靶点的影响
Immunotargets Ther. 2025 Jul 11;14:719-733. doi: 10.2147/ITT.S530451. eCollection 2025.
3
Effect of sheep placenta extract on D-galactose-induced aging mouse.
羊胎盘提取物对D-半乳糖致衰老小鼠的影响。
Front Pharmacol. 2025 Mar 26;16:1498358. doi: 10.3389/fphar.2025.1498358. eCollection 2025.
4
RNA-seq analysis reveals transcriptome changes in livers from knockout mice.RNA测序分析揭示了基因敲除小鼠肝脏中的转录组变化。
Biochem Biophys Rep. 2025 Feb 15;41:101944. doi: 10.1016/j.bbrep.2025.101944. eCollection 2025 Mar.
5
Combined BPA and DIBP Exposure Induced Intestinal Mucosal Barrier Impairment Through the Notch Pathway and Gut Microbiota Dysbiosis in Mice.双酚A和邻苯二甲酸二异丁酯联合暴露通过Notch信号通路和肠道微生物群失调诱导小鼠肠道黏膜屏障损伤
Foods. 2025 Jan 12;14(2):214. doi: 10.3390/foods14020214.
6
A new opportunity for N-acetylcysteine. An outline of its classic antioxidant effects and its pharmacological potential as an epigenetic modulator in liver diseases treatment.N-乙酰半胱氨酸的新机遇。概述其经典抗氧化作用及其作为表观遗传调节剂在肝病治疗中的药理潜力。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2365-2386. doi: 10.1007/s00210-024-03539-0. Epub 2024 Oct 22.
7
Characterization and potential lipid-lowering effects of lactic acid bacteria isolated from cats.从猫体内分离出的乳酸菌的特性及潜在降脂作用
Front Microbiol. 2024 Apr 24;15:1392864. doi: 10.3389/fmicb.2024.1392864. eCollection 2024.
8
Recent advances in age-related metabolic dysfunction-associated steatotic liver disease.年龄相关性代谢功能障碍相关脂肪性肝病的最新进展。
World J Gastroenterol. 2024 Feb 21;30(7):652-662. doi: 10.3748/wjg.v30.i7.652.
9
aggravates high-fat diet-induced non-alcoholic fatty liver disease by regulating lipid metabolism and remodeling gut microbiota.通过调节脂质代谢和重塑肠道微生物群加重高脂肪饮食诱导的非酒精性脂肪肝疾病。
Microbiol Spectr. 2024 Apr 2;12(4):e0339323. doi: 10.1128/spectrum.03393-23. Epub 2024 Feb 27.
10
The influence of the gut microbiome on ovarian aging.肠道微生物组对卵巢衰老的影响。
Gut Microbes. 2024 Jan-Dec;16(1):2295394. doi: 10.1080/19490976.2023.2295394. Epub 2024 Jan 3.